VYNE Therapeutics Inc. (VYNE) Social Stream



VYNE Therapeutics Inc. (VYNE): $0.57

0.02 (+3.76%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VYNE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 450

in industry

VYNE Therapeutics Inc (VYNE) Price Targets From Analysts

Use the tables below to see what analysts covering VYNE Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-16 6 $14 $3 $6.666 $0.644 935.09%
2021-11-11 6 $14 $3 $6.5 $0.644 909.32%
2021-11-11 6 $14 $3 $7.2 $0.644 1018.01%
2021-12-06 6 $14 $3 $7.166 $0.644 1012.73%

VYNE reports an average of 252.7% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 0 40 10 19.43 3.63 435.26%
2021-07-10 0 15 8 11.43 3.10 268.71%
2021-03-06 NA 40 10 19.00 6.68 184.43%
2021-09-18 6 10 3 5.00 1.57 218.47%
2021-09-04 6 10 3 5.00 1.67 199.4%

VYNE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, VYNE Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 397.14% of them.
  • In terms of how VYNE Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -296.23% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, VYNE Therapeutics Inc's average analyst price target is greater than 41.14% of them.
  • In the context of stocks in the small market cap category, VYNE Therapeutics Inc's number of analysts covering the stock is greater than 315.48% of them.

In the Pharmaceutical Products industry, VTYX, VTGN, and VSTM are the three stocks most similar to VYNE Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding VYNE using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5834 seconds.